Zurich Cantonal Bank’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.61M Buy
+68,018
New +$6.87M 0.01% 585
2025
Q4
Sell
-41,801
Closed -$2.74M 3344
2025
Q3
$1.95M Buy
41,801
+3,855
+10% +$151K ﹤0.01% 927
2025
Q2
$1.4M Buy
37,946
+838
+2% +$32.2K ﹤0.01% 1064
2025
Q1
$1.31M Buy
37,108
+6,262
+20% +$254K ﹤0.01% 1019
2024
Q4
$1.35M Buy
30,846
+6,284
+26% +$317K ﹤0.01% 1049
2024
Q3
$1.11M Hold
24,562
﹤0.01% 1072
2024
Q2
$953K Buy
24,562
+7,994
+48% +$299K ﹤0.01% 1093
2024
Q1
$534K Sell
16,568
-3,250
-16% -$96.3K ﹤0.01% 1427
2023
Q4
$568K Buy
19,818
+3,133
+19% +$75.3K ﹤0.01% 1418
2023
Q3
$462K Buy
16,685
+2,199
+15% +$65.2K ﹤0.01% 1448
2023
Q2
$388K Sell
14,486
-767
-5% -$18.8K ﹤0.01% 1512
2023
Q1
$330K Buy
15,253
+4,968
+48% +$122K ﹤0.01% 1553
2022
Q4
$245K Buy
10,285
+3,542
+53% +$75.3K ﹤0.01% 1706
2022
Q3
$133K Hold
6,743
﹤0.01% 2005
2022
Q2
$131K Hold
6,743
﹤0.01% 2052
2022
Q1
$172K Hold
6,743
﹤0.01% 1987
2021
Q4
$170K Buy
6,743
+1,744
+35% +$49.2K ﹤0.01% 2185
2021
Q3
$138K Hold
4,999
﹤0.01% 2149
2021
Q2
$159K Buy
+4,999
New +$174K ﹤0.01% 1958

Other funds holding RVMD

Zurich Cantonal Bank's RVMD Position: Q1 2026 in Review

Zurich Cantonal Bank opened a new position in Revolution Medicines (RVMD) in Q1 2026: 68,018 shares worth $6.61M. The stake represents 0.01% of the portfolio and ranks #585 among its holdings. This is a return to the name: Zurich Cantonal Bank previously reported a position in RVMD as recently as Q3 2025.

Zurich Cantonal Bank first reported a position in RVMD in Q2 2021 and has held it in 19 quarters since. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Zurich Cantonal Bank held 68,018 shares of Revolution Medicines worth $6.61M as of Q1 2026.
  • Revolution Medicines was a new Zurich Cantonal Bank position in Q1 2026.
  • Revolution Medicines made up 0.01% of Zurich Cantonal Bank's portfolio in Q1 2026, its #585 holding.
  • Zurich Cantonal Bank first reported a position in Revolution Medicines in Q2 2021 and has held it in 19 quarters since.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.